Skip to main navigation Skip to search Skip to main content

Homozygous MED25 mutation implicated in eye–intellectual disability syndrome

*Corresponding author for this work
  • Schneider Childrens Medical Center Israel
  • Rabin Medical Center Israel
  • Ariel University
  • Tel Aviv University
  • Molecular Medicine Laboratory
  • CNRS

Research output: Contribution to journalArticlepeer-review

27 Scopus citations

Abstract

Genetic syndromes involving both brain and eye abnormalities are numerous and include syndromes such as Warburg micro syndrome, Kaufman oculocerebrofacial syndrome, Cerebro-oculo-facio-skeletal syndrome, Kahrizi syndrome and others. Using exome sequencing, we have been able to identify homozygous mutation p.(Tyr39Cys) in MED25 as the cause of a syndrome characterized by eye, brain, cardiac and palatal abnormalities as well as growth retardation, microcephaly and severe intellectual disability in seven patients from four unrelated families, all originating from the same village. The protein encoded by MED25 belongs to Mediator complex or MED complex, which is an evolutionary conserved multi-subunit RNA polymerase II transcriptional regulator complex. The MED25 point mutation is located in the von Willebrand factor type A (MED25 VWA) domain which is responsible for MED25 recruitment into the Mediator complex; co-immunoprecipitation experiment demonstrated that this mutation dramatically impairs MED25 interaction with the Mediator complex in mammalian cells.

Original languageEnglish
Pages (from-to)577-587
Number of pages11
JournalHuman Genetics
Volume134
Issue number6
DOIs
StatePublished - 1 Jun 2015

Funding

FundersFunder number
Israeli Ministry of Health Chief Scientist Foundation3-4963
Rambam Medical Center
Israel Science Foundation558/09

    Fingerprint

    Dive into the research topics of 'Homozygous MED25 mutation implicated in eye–intellectual disability syndrome'. Together they form a unique fingerprint.

    Cite this